We are seeing more Biotechs choose Reg A+ to raise capital. Reg A+ is a great fit for Biotechs that have strong consumer appeal or that are clearly poised for rapid capital appreciation.
In this webinar, Rod Turner will be discussing Reg A+ Biotech offerings and both the obvious and the subtle nuances of making your Reg A+ a great success.
– What is Reg A+
– Advantages of using Reg A+ instead of VC
– Why Reg A+ can be a great fit for Biotech companies
– Reg A+ offering timeline
– Broker-dealer involvement
– Marketing and costs
– Minimum and Maximum capital raise
– Post-offering liquidity options
– Mistakes to avoid
Questions and Answers – You are welcome to send us your questions ahead of time. We will also answer live questions toward the end of the Webinar.
Sign up and we will send you your reservation and Zoom conference invitation.
Note: If you have not received your confirmation email, send an email to us at Support@ManhattanStreetCapital.com using the same email that you signed up with.